Michael Sherman

Michael Sherman

Director/Board Member at WEREWOLF THERAPEUTICS, INC.

Net worth: - $ as of 31/05/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

Michael A. Sherman is currently Director at The Children's Museum of Indianapolis, Inc. since 2012, Director at TOLREMO therapeutics AG, Independent Director at Werewolf Therapeutics, Inc. since 2021, and Independent Director at Aktis Oncology, Inc. starting in 2025.
Former roles include President, Chief Executive Officer & Director at Endocyte, Inc. from 2017 to 2018, Chairman at Chimerix, Inc. from 2023 to 2025, Independent Director at BioSpecifics Technologies Corp.
in 2020, Independent Director at Mead Johnson Nutrition Co. from 2015 to 2017, Vice President-Finance & Strategic Planning at Guidant Corp.
from 2004 to 2006, and Principal at Eli Lilly & Co. Education includes undergraduate studies at DePauw University and an MBA from Tuck School of Business at Dartmouth.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2025 0 ( -.--% ) - $ 31/05/2026

Michael Sherman active positions

CompaniesPositionStart
WEREWOLF THERAPEUTICS, INC. Director/Board Member 27/05/2021
AKTIS ONCOLOGY, INC. Director/Board Member 01/08/2025
Director/Board Member -
Director/Board Member -

Former positions of Michael Sherman

CompaniesPositionEnd
CHIMERIX, INC. Chief Executive Officer 01/08/2023
BIOSPECIFICS TECHNOLOGIES CORP. Director/Board Member 02/12/2020
ENDOCYTE, INC. Chief Executive Officer 21/12/2018
MEAD JOHNSON NUTRITION CO Director/Board Member 15/06/2017
Director of Finance/CFO 01/10/2006
See the detail of Michael Sherman's experience

Training of Michael Sherman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Consumer Services

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Sherman